Oklahoma Regulator Suspends a Cannabis Lab’s License
Complete the form below and we will email you a PDF version of "Oklahoma Regulator Suspends a Cannabis Lab’s License"
State regulators in Oklahoma have temporarily suspended a medical cannabis testing lab’s license due to alleged violations.
The Oklahoma Medical Marijuana Authority (OMMA) has also recalled 99 medical cannabis products tested by the lab.
The OMMA regulators first became suspicious that the lab, Scale Laboratories in Oklahoma City, was violating testing regulations during routine inspections in mid-April.
The lab reportedly “passed” 138 samples that had higher than acceptable levels of total yeast and mold. Nine samples also failed testing for Aspergillus, five failed for E. coli, and one failed for Salmonella – and all related products still “passed” testing.
The inspectors also noted that lab workers didn’t use keep appropriate records for testing, manipulated data, and routinely deviated from standard procedures.
“We are first and foremost concerned about the health, safety and welfare of patients who might consume harmful marijuana products,” OMMA's executive director, Adria Berry, said in a statement.
“Let this serve as a warning to any licensee attempting to skirt state laws: We work diligently behind the scenes to find and take down the bad actors within this industry. If you’re engaging in actions that threaten the health and safety of Oklahomans, you won’t get away with it,” Berry continued.
“Our inspection teams are working across the state to keep Oklahomans safe by identifying problems and gathering the necessary evidence to help shut down bad actors that choose to break the law.”
In light of its findings, OMMA issued a recall of 99 products tested by Scale Laboratories on Thursday, May 19. The products include cannabis flower, concentrates, pre-rolls, and edibles. Further details, including strain names and batch IDs can be found here.
The recall affects 33 businesses across the state. Dispensaries has been advised to contact patients who purchased the recalled products.
Any patient with questions about the recall has been advised to contact their dispensary and return any products of concern.